Doximity (NYSE:DOCS – Get Free Report) and Oblong (NASDAQ:OBLG – Get Free Report) are both services companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation.
Profitability
This table compares Doximity and Oblong’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Doximity | 40.72% | 24.63% | 21.30% |
| Oblong | -187.17% | -62.63% | -52.38% |
Volatility and Risk
Doximity has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Comparatively, Oblong has a beta of 3.12, suggesting that its share price is 212% more volatile than the S&P 500.
Institutional and Insider Ownership
Earnings and Valuation
This table compares Doximity and Oblong”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Doximity | $570.40 million | 13.57 | $223.18 million | $1.26 | 32.63 |
| Oblong | $2.38 million | 2.85 | -$4.04 million | ($1.71) | -1.23 |
Doximity has higher revenue and earnings than Oblong. Oblong is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings and target prices for Doximity and Oblong, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Doximity | 0 | 2 | 1 | 2 | 3.00 |
| Oblong | 1 | 0 | 0 | 0 | 1.00 |
Summary
Doximity beats Oblong on 13 of the 14 factors compared between the two stocks.
About Doximity
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
About Oblong
Oblong Inc., together with its subsidiaries, provides multi-stream collaboration technologies and managed services for video collaboration and network applications in the United States and internationally. The company operates in two segments, Collaboration Products and Managed Services. Its flagship product is Mezzanine that enables visual collaboration across multi-users, multi-screens, multi-devices, and multi-locations for video telepresence, laptop and application sharing, and whiteboard sharing and slides applications. The company also provides managed videoconferencing services; and remote service management, which provides an overlay to enterprise information technology and channel partner support organizations, as well as support and management services for customer video environments. In addition, it offers network services comprising Cloud Connect: Video that allows its customers to outsource the management of their video traffic to them and provides the customer’s office locations with a secure, dedicated video network connection to the Oblong Cloud for video communications; Cloud Connect: Converge, which offers customized multiprotocol label switching solutions; and Cloud Connect: Cross Connect that allows the customer to leverage existing carrier for the extension of a Layer 2 private line to its data center. Further, it provides professional services, such as software development, visual and interaction design, engineering, and project support services; and resells video equipment to its customers. Oblong Inc. is based in Conifer, Colorado.
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
